UNSPSC 51343006: Indinavir sulfate

This classification denotes a protease inhibitor and anti-hiv agent, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 5W6YA9PKKH. European Medicines Agency schedules Indinavir sulfate in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB02666MIG. Indinavir sulfate generally arises in the molecular formula C36H47N5O4.H2O4S. The term 'indinavir sulfate' is a European Medicines Agency European Public Assessment Report System designation.

UNSPSC 51343006 Indinavir sulfate is a Commodity code that nominally designates a specific antiretroviral pharmaceutical, but recent state and local procurement activity under this code shows little or no purchasing aligned with the code's stated scope. The recent opportunities posted under this code — Seminole County's procurement for naloxone and drug deactivation systems, the City of Tampa's bid for medical and first aid supplies for fire rescue operations, the Texas HHS Commission's RFI on direct-to-manufacturer prescription programs, and the Minnesota Multistate Cooperative Purchasing Alliance's RFP for generic multi-source pharmaceuticals and OTC products — represent broad medical supply, emergency response consumables, and pharmacy benefit management initiatives, none of which target indinavir sulfate or HIV antiretroviral therapy specifically. The mismatch between the code name and the actual work being solicited suggests that this code may be misapplied or inactive for its intended product category in current state and local contracting.

Geographic activity spans Florida (Seminole County), Texas (HHS Commission), Minnesota (MMCAP, serving multiple states including Oregon), and Florida again (City of Tampa), though the opportunities reflect exploratory-stage procurement and emergency-supply replenishment rather than systematic demand for the named pharmaceutical. The issuing bodies include county health departments, municipal fire services, state health and human services agencies, and multistate cooperative purchasing alliances — a mix typical of broad pharmaceutical and medical-supply procurement. Without recent opportunities explicitly targeting indinavir sulfate or antiretroviral drugs, this code presents limited pursuit value for vendors specializing in that therapeutic category; business development efforts would be better directed toward pharmaceutical codes with active, aligned demand signals or toward the broader medical and first aid supply codes where state and local activity is visible.